Birkenstock Proves Premium Still Sells, Even as the Rest of Retail Struggles

Birkenstock stock rose 6.3% to $33.80 after JPMorgan reaffirmed its Overweight rating and $58 price target, citing management's 13-15% revenue growth guidance. The stock was near its 52-week low, and JPMorgan projects 35% FY2027 EPS growth, above consensus. The broader market also gained, with the S&P 500 up 0.4% and the Dow Jones up 0.8%.

BMO Capital initiated coverage on Birkenstock (NYSE:BIRK) with a Market Perform rating and a $35.00 price target. The stock has fallen 16.9% year-to-date, trading near its 52-week low. BMO acknowledges Birkenstock's strong brand and supply chain but expresses caution due to maturing growth in key markets. Analysts have revised earnings downward, though revenue grew 11.8% over the last year. Recent developments include a secondary share offering and price target increases from other analysts.

Birkenstock (BIRK) shares fell 9.4% after raising 2026 revenue guidance to 15%, targeting EUR 2.3-2.35B. The company announced a $1B equity offering and $500M share buyback. Despite higher sales, profits softened, and shares are down over 30% year-to-date.

Birkenstock (BIRK) reported Q3 2026 revenue of EUR 720M, up 15% in constant currency, and raised full-year guidance. Adjusted EBITDA grew 11% to EUR 242M, while adjusted EPS increased 19% to EUR 0.74. DTC sales outpaced B2B for the first time in eight quarters. The company issued EUR 900M in senior notes and repurchased EUR 230M in shares. Management cited strong demand in APAC, particularly China, and noted risks from Middle East conflicts and closed-toe product margin drag.

Birkenstock's adjusted EBITDA margin slipped to 33.7% due to FX and tariff headwinds. Operating cash flow was $250M, but net leverage rose to 1.8x. A $1B secondary offering by L Catterton, not Birkenstock, caused a 4% stock drop. Birkenstock's buyback offsets dilution. Analysts rate BIRK a Moderate Buy with a $53.91 target.

Birkenstock Holding (BIRK) raised its fiscal 2026 revenue guidance to 15% constant-currency growth, citing stronger-than-expected Q3 sales and an updated adjusted EBITDA outlook. The stock was $39.35, down 11.29% over 30 days and up 21.08% over 90 days. Simply Wall St’s model values it at $43.11, about 9% undervalued.